Clinical Trials on Vasculitis in Germany
Total 49 results
-
Charite University, Berlin, GermanyNovartis PharmaceuticalsCompletedVasculitis | UrticariaGermany
-
University Hospital MuensterUnknown
-
University Hospital Schleswig-HolsteinGlaxoSmithKlineCompletedChurg Strauss SyndromeGermany
-
Vifor Fresenius Medical Care Renal PharmaRecruiting
-
Nippon Kayaku Co., Ltd.CompletedWegener's GranulomatosisUnited Kingdom, Germany, Sweden, Czech Republic, Denmark, Netherlands
-
Universitätsmedizin MannheimUnknownIdiopathic Pulmonary Fibrosis | Interstitial Lung Disease | Sarcoidosis | Pulmonary Healthy Controls | Non-specific Interstitial Pneumonia | Granulomatosis With Polyangiitis (Wegener's Disease)Germany
-
ChemoCentryxCompletedA Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis (ADVOCATE)ANCA-Associated VasculitisUnited States, Australia, Belgium, Canada, France, Italy, Japan, Netherlands, Spain, United Kingdom, Austria, Czechia, Denmark, Germany, Hungary, Ireland, New Zealand, Norway, Sweden, Switzerland
-
University of South FloridaBristol-Myers Squibb; University of Pennsylvania; National Institute of Arthritis... and other collaboratorsActive, not recruitingWegener's Granulomatosis | Granulomatosis With Polyangiitis | ANCA-Associated Vasculitis | Granulomatosis With Polyangiitis (Wegener's)United States, United Kingdom, Ireland, Canada, Germany
-
University of BonnActive, not recruiting
-
University Hospital TuebingenCompletedPanuveitis | Posterior Uveitis | Retinal Vasculitis | Behcet's DiseaseGermany
-
Matthias FröhlichCompleted
-
NovartisCompletedSuperficial Thrombophlebitis of the Upper LimbGermany
-
University Hospital MuensterCompletedSepsis | Pre-Eclampsia | Adiposity | Microscopic Polyangiitis | Granulomatosis With Polyangiitis | SIRS | ProcalcitoninGermany
-
Sparrow PharmaceuticalsRecruitingA Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)Polymyalgia RheumaticaGermany
-
University of BonnRecruitingGiant Cell ArteritisGermany
-
AstraZenecaActive, not recruitingEosinophilic Granulomatous VasculitisUnited States, Canada, France, Italy, Israel, United Kingdom, Japan, Germany, Belgium
-
Sparrow PharmaceuticalsRecruitingPolymyalgia RheumaticaGermany
-
University of GöttingenUniversity Medical Center GoettingenUnknownSystemic Lupus Erythematosus | Vasculitis | MyositisGermany
-
University of British ColumbiaUniversity of Oxford; BC Childrens Hospital Research InstituteRecruitingMicroscopic Polyangiitis | Polyarteritis Nodosa | Eosinophilic Granulomatosis With Polyangiitis | Takayasu Arteritis | Wegeners Granulomatosis (Granulomatosis With Polyangiitis) | Primary CNS Vasculitis | Unclassified VasculitisCanada, United States, Thailand, United Kingdom, Germany, India, Denmark
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedVasculitisUnited States, Australia, France, Spain, Italy, Peru, Belgium, Canada, Germany, Romania, Mexico, United Kingdom, Hungary, Ireland, Poland, Switzerland, Czechia, Russian Federation, Norway, Sweden
-
Hoffmann-La RocheCompletedGranulomatosis With PolyangiitisUnited States, Canada, United Kingdom, Germany, Italy, Serbia, Turkey, France
-
Novartis PharmaceuticalsCompleted
-
Robert Bosch Gesellschaft für Medizinische Forschung...CompletedHypertension | Diabetes | Vasculitis | Hypercholesterolemia | Coronary Heart DiseasesGermany
-
Novartis PharmaceuticalsTerminatedPolymyalgia Rheumatica | Inflammatory DiseasesGermany, Italy, United States, United Kingdom
-
GlaxoSmithKlineNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With PolyangiitisChurg-Strauss SyndromeUnited States, France, Japan, Spain, Italy, Germany, Canada, Belgium, United Kingdom
-
InflaRx GmbHCompletedGranulomatosis With Polyangiitis (GPA) | Microscopic Polyangiitis (MPA)Germany, Russian Federation, Belgium, France, Spain, Czechia, Italy, Netherlands, Sweden, Switzerland, United Kingdom
-
GlaxoSmithKlineCompletedChurg-Strauss Syndrome | Eosinophilic Granulomatosis With PolyangiitisUnited States, France, Japan, Germany, Canada, United Kingdom, Belgium
-
ChemoCentryxCompletedVasculitisFrance, United Kingdom, Germany, Belgium, Poland, Netherlands, Hungary, Austria, Sweden, Czechia
-
Novartis PharmaceuticalsRecruiting
-
University of OxfordLondon School of Hygiene and Tropical Medicine; The Leeds Teaching Hospitals... and other collaboratorsCompletedGiant Cell ArteritisIreland, United Kingdom, Germany, Norway, Portugal
-
GlaxoSmithKlineRecruitingEosinophilic Granulomatosis With PolyangiitisCanada, France, Italy, Spain, Belgium, Korea, Republic of, United States, Japan, China, Czechia, Hungary, Israel, Portugal, Poland, Netherlands, United Kingdom, Austria, Argentina, Australia, Brazil, Germany, Sweden
-
Janssen Research & Development, LLCActive, not recruitingGiant Cell ArteritisUnited States, Canada, Belgium, Israel, Italy, Germany, France, Spain, Poland
-
Kiniksa Pharmaceuticals, Ltd.CompletedGiant Cell ArteritisUnited States, Belgium, Croatia, Germany, Italy, Poland, Serbia, United Kingdom, Australia, Estonia, Ireland, Netherlands, New Zealand, Slovenia, Spain
-
University of OxfordAmerican College of Rheumatology; The European League Against Rheumatism (EULAR) and other collaboratorsUnknownGiant Cell Arteritis | Wegener's Granulomatosis | Microscopic Polyangiitis | Polyarteritis Nodosa | Takayasu Arteritis | Churg Strauss SyndromeKorea, Republic of, United States, Germany, Australia, Japan, Ireland, Belgium, Italy, Denmark, Slovenia, Switzerland, Canada, Argentina, Austria, China, Czech Republic, Egypt, Finland, France, Hungary, India, Mexico, Netherlands, New... and more
-
SanofiRegeneron PharmaceuticalsTerminatedGiant Cell ArteritisArgentina, Estonia, France, United States, Australia, Belgium, Canada, Croatia, Denmark, Germany, Hungary, Israel, Italy, Netherlands, Portugal, Russian Federation, Slovenia, Spain, Sweden, Switzerland, United Kingdom
-
GlaxoSmithKlineTerminatedGiant Cell ArteritisUnited States, Spain, Germany, Italy, Belgium, France, Netherlands, Australia, United Kingdom, Hungary, Poland, Bulgaria, New Zealand
-
SanofiRegeneron PharmaceuticalsTerminatedPolymyalgia RheumaticaArgentina, Estonia, France, Japan, United States, Australia, Belgium, Canada, Germany, Hungary, Israel, Italy, Netherlands, Russian Federation, Switzerland, United Kingdom, Spain
-
Hoffmann-La RocheCompletedGiant Cell ArteritisUnited States, United Kingdom, Sweden, Belgium, Netherlands, Germany, Spain, Norway, Poland, France, Italy, Canada, Denmark, Portugal
-
Bristol-Myers SquibbWithdrawnGiant Cell ArteritisPoland, United States, Spain, France, Austria, Belgium, Italy, Romania, Switzerland, Germany, Greece, Netherlands, Australia, Denmark, United Kingdom, Ireland, Bulgaria, Canada, Estonia, Serbia, Sweden
-
GlaxoSmithKlineCompletedThrombosis, VenousNetherlands, Spain, Germany, Italy, Poland, Russian Federation, France, Israel, Estonia, Hungary, Slovakia, Latvia, Greece, Ukraine, Czech Republic, Switzerland, Bulgaria
-
AbbVieTerminatedPolymyalgia RheumaticaUnited States, Australia, Austria, Canada, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Novartis PharmaceuticalsRecruitingPolymyalgia RheumaticaUnited States, Australia, Germany, Belgium, France, Spain, Italy, Lebanon, Switzerland, Japan, Israel, Denmark, Argentina, Netherlands, Colombia, Chile, Hungary, Poland, Turkey, Czechia, Brazil, South Africa, Mexico, Canada, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingGiant Cell Arteritis (GCA)United States, Belgium, Hungary, Italy, Turkey, Austria, Spain, Switzerland, France, Germany, Israel, Australia, Denmark, Greece, United Kingdom, Guatemala, Bulgaria, Czechia, Estonia, Argentina, Canada, Brazil, Sweden, Finland, Poland, P... and more
-
AbbVieActive, not recruitingGiant Cell Arteritis (GCA)United States, Australia, Austria, Belgium, Canada, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Netherlands, New Zealand, Norway, Portugal, Romania, Russian Federation, Spain, Sweden, Switzerland, United...
-
University Hospital, GrenobleSanofi; Ministry of Health, France; SFMV (Société Française de Médecine Vasculaire)CompletedVascular Diseases | Embolism and Thrombosis | Venous Insufficiency | Phlebitis | Pulmonary EmbolismFrance, Belgium, Guadeloupe
-
Travere Therapeutics, Inc.RecruitingFocal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | Minimal Change Disease | Alport Syndrome | IgA VasculitisUnited States, Italy, Netherlands, Poland, Spain, United Kingdom, Germany, Sweden
-
Novartis PharmaceuticalsCompletedBehcet DiseaseIndia, Turkey, Spain, Germany, Italy, France, Israel, Greece, Korea, Republic of, Hong Kong, United States, Egypt, Jordan, Singapore, Switzerland, Taiwan, Tunisia
-
AmgenCompletedBehçet's SyndromeUnited States, Korea, Republic of, Israel, Italy, Turkey, France, Germany, Greece, Lebanon, Japan
-
University of SienaRecruitingBehcet Syndrome | Uveitis | Hereditary Autoinflammatory Diseases | Schnitzler Syndrome | Scleritis | PFAPA Syndrome | Still Disease | Autoinflammatory Syndrome, Unspecified | Vexas SyndromeEgypt, Spain, Turkey, Italy, Saudi Arabia, Greece, Belgium, United States, Algeria, Brazil, Germany, Ghana, Iran, Islamic Republic of, Lebanon, Morocco, Poland, Portugal, Romania, Taiwan